Lamivudine is one of the best tolerated medicines in HIV care and, arguably, in any field. Most people notice nothing at all.
What happens in the first weeks?
Headache, nausea, tiredness, abdominal discomfort or loose stools occur in a minority and generally settle within two to four weeks. They are mild where they occur.
Why is it so well tolerated?
Because it has minimal effect on human cellular processes. Unlike the older thymidine analogues, it does not significantly interfere with the enzyme that copies DNA in mitochondria, which is what caused fat loss, neuropathy and muscle problems with those drugs.
Does it affect kidneys?
Not as a toxicity. It is cleared by the kidneys, which means the dose is reduced where function is impaired, and it does not itself damage them. Kidney monitoring on a combination containing it usually relates to a tenofovir component.
Does it affect bones?
No. Bone density effects seen with some combinations relate to tenofovir disoproxil rather than to lamivudine.
Does it cause weight gain?
Not attributed to it. Weight changes reported with modern regimens have been associated with integrase inhibitors and with tenofovir alafenamide rather than with this component.
What about hepatitis B?
Not a side effect of taking it but of stopping. Lamivudine suppresses hepatitis B, so abrupt withdrawal in someone with chronic infection can cause a serious flare of liver inflammation, occasionally severe.
Is that likely?
Real enough to shape practice. Hepatitis B status is checked before starting, and anyone with chronic infection who stops lamivudine needs liver monitoring afterwards rather than simply ceasing.
What about pancreatitis?
Reported rarely, mainly in children and in people with advanced HIV disease or a previous history. Severe upper abdominal pain radiating to the back, with vomiting, warrants urgent assessment.
What about lactic acidosis?
Reported with this class, uncommonly with lamivudine specifically. Severe abdominal pain, marked breathlessness, unusual weakness or persistent vomiting warrant prompt attention rather than waiting for an appointment.
What about allergic reactions?
Uncommon. Any rash accompanied by fever, blistering, peeling skin, or involvement of the mouth or eyes is an emergency regardless of which medicine caused it.
How do you tell which component is responsible?
With lamivudine, usually by elimination: if you are struggling on a combination tablet, the odds strongly favour another component. A clinician can narrow it by pattern and timing, and switching one part is frequently possible.
Do side effects mean it is working?
No, and their absence does not mean it is not. There is no relationship between how you feel and how well the virus is being suppressed. Blood tests are the only reliable measure.
What monitoring is there?
Blood tests every three to six months covering viral load, kidney and liver function. Kidney function matters because it determines the appropriate dose.
When should you contact your clinic?
Anything lasting beyond a month, severe abdominal pain, any rash with systemic symptoms, or anything making you consider stopping. If you are struggling on a combination, ask which component is likely responsible.
Should you look side effects up online?
The leaflet lists everything ever reported, which is alarming and unhelpful for judging likelihood. A clinic pharmacist will tell you which effects are common and which matter, in about two minutes.
What is worth recording?
When something started, how long it lasts, and whether anything else changed at the same time. A short note is considerably more useful at an appointment than trying to reconstruct whether a symptom followed starting lamivudine or something else.
Are side effects a reason to stop?
Not to stop, and often a reason to change. Stopping leaves you untreated; switching keeps you covered. Nearly every effect described here has an alternative regimen that avoids it, so the conversation is worth having.
Do experiences differ between people?
Substantially. Two people on identical regimens can have completely different experiences, which is why general descriptions only go so far. Your own first month is more informative than any list of possibilities.